Safety and Immunogenicity of Conventional Subunit and MF59-adjuvanted Influenza Vaccines in Human Immunodeficiency Virus-1-seropositive Patients

Author： Gabutti G   Guido M   Durando P   de Donno A   Quattrocchi M   Bacilieri S   Ansaldi F   Cataldini S   Chiriacò PG   de Simone M   Minniti S   Sticchi L   Gasparini R  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.33, Iss.4, 2005-07, pp. : 406-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adding MF59 adjuvant to a subvirion H5N1 influenza A virus vaccine appears to increase immunogenicity

By  

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1433-1439

Bentham Science Publishers

Access to resources Recommend Favorite

M59-adjuvanted vaccine against H5N1 influenza antigenic in volunteers

By  

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

MF59-adjuvated influenza vaccine dominant in the elderly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature

By Beyer W.E.P.   Palache A.M.   Osterhaus A.D.M.E.  

Clinical Drug Investigation, Vol. 15, Iss. 1, 1998-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite